Defence Therapeutics Invites Shareholders to Its December 10, 2026, Annual General Meeting and 2027 Strategic Update
Montreal, Quebec--(Newsfile Corp. - November 16, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to invite shareholders to its upcoming Annual General Meeting ("AGM" or the "Meeting") on December 10, 2026, in Montreal, Quebec, with the option to participate virtually.This year's AGM will mark Defence's first Annual General Meeting under the leadership...